Congenital myopathies and muscular dystrophies yielded a comparable ‘solved’ rate of 53%, spanning 16 genes, including known variants in STAC3, RYR1 and COL6A2/3 in addition to 21 novel variants across 14 genes. This evidence concerns the gene STAC3 and muscular dystrophy.